Skip to main content

Cocrystal Pharma, Inc.

COCP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001412486

In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Cocrystal Pharma, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
22
0 vs. Q2 2025
Shares held
665.0K
−21.5K (−3.1%) vs. Q2 2025
Total value
$831.3K
−$191.7K (−18.7%) vs. Q2 2025
New holders
4
3 more added
Sold out
4
4 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting COCP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 22 institutions
Q1 2021: 35 institutionsQ2 2021: 42 institutionsQ3 2021: 41 institutionsQ4 2021: 35 institutionsQ1 2022: 34 institutionsQ2 2022: 33 institutionsQ3 2022: 27 institutionsQ4 2022: 21 institutionsQ1 2023: 21 institutionsQ2 2023: 20 institutionsQ3 2023: 16 institutionsQ4 2023: 17 institutionsQ1 2024: 16 institutionsQ2 2024: 14 institutionsQ3 2024: 20 institutionsQ4 2024: 24 institutionsQ1 2025: 24 institutionsQ2 2025: 22 institutionsQ3 2025: 22 institutionsQ4 2025: 28 institutionsQ1 2026: 26 institutionsQ2 2026: 27 institutions
Value heldQ3 2025: $831.3K
Q1 2021: $13.5MQ2 2021: $25.0MQ3 2021: $16.1MQ4 2021: $9.78MQ1 2022: $7.90MQ2 2022: $5.83MQ3 2022: $3.95MQ4 2022: $2.08MQ1 2023: $1.47MQ2 2023: $1.59MQ3 2023: $1.32MQ4 2023: $1.17MQ1 2024: $1.01MQ2 2024: $1.57MQ3 2024: $1.27MQ4 2024: $1.44MQ1 2025: $1.06MQ2 2025: $1.02MQ3 2025: $831.3KQ4 2025: $754.3KQ1 2026: $783.8KQ2 2026: $1.17M
Institutions holding COCP and their total value by quarter
QuarterHoldersValue
Q2 202627$1.17M
Q1 202626$783.8K
Q4 202528$754.3K
Q3 202522$831.3K
Q2 202522$1.02M
Q1 202524$1.06M
Q4 202424$1.44M
Q3 202420$1.27M
Q2 202414$1.57M
Q1 202416$1.01M
Q4 202317$1.17M
Q3 202316$1.32M
Q2 202320$1.59M
Q1 202321$1.47M
Q4 202221$2.08M
Q3 202227$3.95M
Q2 202233$5.83M
Q1 202234$7.90M
Q4 202135$9.78M
Q3 202141$16.1M
Q2 202142$25.0M
Q1 202135$13.5M

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Cocrystal Pharma, Inc.; share changes are against Q2 2025.

Institutions holding COCP in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc268,080$335.1K0.00%00.0%Unchanged
Renaissance Technologies LLC127,928$159.9K0.00%+2,900+2.3%Added
Geode Capital Management, LLC73,929$92.4K0.00%+829+1.1%Added
BlackRock, Inc.73,746$92.2K0.00%00.0%Unchanged
Neuberger Berman Group LLC31,886$39.9K0.00%+31,886New
Jane Street Group, LLC21,044$26.3K0.00%+21,044New
State Street Corp20,543$25.7K0.00%00.0%Unchanged
Parallel Advisors, LLC12,611$15.8K0.00%−2,617−17.2%Reduced
Northern Trust Corp11,921$14.9K0.00%00.0%Unchanged
Bank of America Corp9,092$11.4K0.00%−9−0.1%Reduced
Morgan Stanley5,863$7.33K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)3,298$4.12K0.00%−365−10.0%Reduced
Wells Fargo & Company1,812$2.27K0.00%00.0%Unchanged
Citigroup Inc1,053$1.32K0.00%+1,053New
Northwestern Mutual Wealth Management Co817$1.02K0.00%00.0%Unchanged
UBS Group AG571$7140.00%−21,344−97.4%Reduced
Clean Yield Group418$5230.00%00.0%Unchanged
MAI Capital Management237$2970.00%00.0%Unchanged
NVWM, LLC84$1050.00%00.0%Unchanged
SBI Securities Co., Ltd.34$430.00%+1+3.0%Added
Barclays PLC16$200.00%+16New
Royal Bank of Canada51$00.00%00.0%Unchanged
Activest Wealth Management0$00.00%−1−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−40,619−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−14,092−100.0%Sold out
Raymond James Financial Inc0$00.00%−215−100.0%Sold out